Comparative nonclinical assessments of the biosimilar PF-06410293 and originator adalimumab.
Regul Toxicol Pharmacol
; 112: 104587, 2020 Apr.
Article
in En
| MEDLINE
| ID: mdl-32006671
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Biosimilar Pharmaceuticals
/
Adalimumab
Limits:
Animals
/
Female
/
Humans
/
Male
Country/Region as subject:
America do norte
Language:
En
Year:
2020
Type:
Article